Pharmacology of Cognition in Schizotypal Personality
ID Number 95-0650Principal Investigator(s)
Larry J. Siever
Department(s) or Division(s)
The purpose of this study is to examine the effects of the administration of a drug called GUANFACINE (Tenex) on attention, concentration, memory and motivation in persons with schizotypal personality disorder (SPD). This drug is approved for the treatment of high blood pressure but is not currently approved for use in schizotypal personality disorder.
Recruiting Patients: Yes